Skip to main content
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. — Investor Relations & Filings

Ticker · EBS ISIN · US29089Q1058 LEI · 549300YW6TUOX8BE5103 US Manufacturing
Filings indexed 1,264 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country US United States of America
Listing US EBS

About Emergent BioSolutions Inc.

https://emergentbiosolutions.com/

Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.

Recent filings

Filing Released Lang Actions
8-K - Emergent BioSolutions Inc. (0001367644) (Filer)
Regulatory Filings
2026-04-30 English
8-K - Emergent BioSolutions Inc. (0001367644) (Filer)
Regulatory Filings
2026-04-30 English
SCHEDULE 13G/A - Emergent BioSolutions Inc. (0001367644) (Subject)
Major Shareholding Notification
2026-03-26 English
ARS - Emergent BioSolutions Inc. (0001367644) (Filer)
Annual Report FY 2025
2026-03-20 English
DEFA14A - Emergent BioSolutions Inc. (0001367644) (Filer)
Regulatory Filings
2026-03-20 English
DEF 14A - Emergent BioSolutions Inc. (0001367644) (Filer)
Proxy Solicitation & Information Statement
2026-03-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.